Mri Compatible Iv Infusion Pump Systems was Iradimed’s largest revenue line in fiscal 2017, bringing in $13.62M of $23.08M (59%).
| Products and Services | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|
| Mri Compatible Iv Infusion Pump Systems | — | $26.33M | $25.49M | $13.62M | |
| Devices | $12.81M | — | — | — | |
| Disposable Iv Sets & Services | $2.84M | $5.24M | $6.71M | $7.61M | |
| Mri Compatible Patient Vital Signs Monitoring Systems | — | $26.78K | $293.55K | $1.85M | |
| Total | $15.65M | $31.59M | $32.50M | $23.08M |
Iradimed brought in $23.08M from its three revenue lines in fiscal 2017, the year ended December 31, 2017. That was down 29.0% from $32.50M in fiscal 2016. Mri Compatible Iv Infusion Pump Systems was the largest at $13.62M (59.0%), ahead of Disposable Iv Sets & Services at $7.61M (33.0%) and Mri Compatible Patient Vital Signs Monitoring Systems at $1.85M (8.0%).
Compared with fiscal 2016, Mri Compatible Patient Vital Signs Monitoring Systems grew fastest, up 529.7% to $1.85M, while Mri Compatible Iv Infusion Pump Systems fell the most, down 46.6% to $13.62M.
Iradimed began breaking out Mri Compatible Iv Infusion Pump Systems in fiscal 2015 and Mri Compatible Patient Vital Signs Monitoring Systems in fiscal 2015. Iradimed stopped reporting Devices as a separate revenue line after fiscal 2014, when it brought in $12.81M.
United States was Iradimed’s largest region in fiscal 2017, bringing in $19.50M of $23.08M (84%).
| Geography | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|
| United States | $11.36M | $28.85M | $28.90M | $19.50M | |
| International | $4.30M | $2.74M | $3.59M | $3.58M | |
| Total | $15.65M | $31.59M | $32.50M | $23.08M |
Iradimed brought in $23.08M from its two regions in fiscal 2017, the year ended December 31, 2017. That was down 29.0% from $32.50M in fiscal 2016. United States was the largest at $19.50M (84.5%), ahead of International at $3.58M (15.5%).
Compared with fiscal 2016, International fell 0.4% to $3.58M and United States fell 32.5% to $19.50M. From fiscal 2014 to 2017, combined revenue from these regions grew from $15.65M to $23.08M, a compound annual growth rate of 13.8%. United States' share of the total rose from 72.6% to 84.5%.
Iradimed (IRMD) reports its revenue by products and services and by geography. In fiscal 2017, Mri Compatible Iv Infusion Pump Systems was its largest revenue line, bringing in $13.62M (59.0% of the total), followed by Disposable Iv Sets & Services at $7.61M (33.0%).
Mri Compatible Iv Infusion Pump Systems was Iradimed's largest revenue line in fiscal 2017, bringing in $13.62M, or 59.0% of the $23.08M total across its three revenue lines.
United States was Iradimed's largest region in fiscal 2017, bringing in $19.50M, or 84.5% of the $23.08M total across its two regions.
Among Iradimed's revenue lines that make up at least 2% of revenue, Mri Compatible Patient Vital Signs Monitoring Systems grew fastest in fiscal 2017, up 529.7% from $293.55K to $1.85M.
Every figure comes from Iradimed's annual financial filings, as reported. Each line keeps the name Iradimed gives it, and years follow its fiscal calendar.
Iradimed's revenue by products and services goes back to fiscal 2013, with figures through fiscal 2017. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.